C282Y and H63D were analyzed in the peripheral blood, while serum cardiac troponin-T (cTnT) and N-terminal probrain natriuretic peptide (NT-proBNP), biomarkers for heart injury and cardiomyopathy, were measured during treatment. Here, TNNT2 is linked to cardiomyopathy.